Beta-arrestin2 as a competitor for GRK2 interaction with the GLP-1 receptor upon receptor activation

Pharmacology

Volumn 88, Issue 3-4, 2011, Pages 174-181

  Jorgensen, Rasmus ^b   Norklit Roed, Sarah ^a   Heding, Anders ^b   Elling, Christian E ^c  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c 7TM Pharma A S   (Denmark)

Author keywords

arrestin; Bioluminescence resonance energy transfer; G protein coupled receptor kinase; G protein coupled receptors; Glucagon like peptide 1

Indexed keywords

BETA ARRESTIN 2; G PROTEIN COUPLED RECEPTOR KINASE 2; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ARRESTINS; BINDING, COMPETITIVE; DNA, COMPLEMENTARY; ENERGY TRANSFER; G-PROTEIN-COUPLED RECEPTOR KINASE 2; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LUCIFERASES, RENILLA; LUMINESCENT MEASUREMENTS; PHOSPHORYLATION; RECEPTORS, GLUCAGON; RECOMBINANT FUSION PROTEINS;

EID: 80155136181     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000330742     Document Type: Article

References (30)

1. Bunemann M, Hosey MM: G-protein coupled receptor kinases as modulators of Gprotein signalling. J Physiol 1999; 517: 5-23. (Pubitemid 29243467)
2. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ: beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 1990; 248: 1547-1550.
3. Lefkowitz RJ, Shenoy SK: Transduction of receptor signals by beta-arrestins. Science 2005; 308: 512-517.
4. Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL: Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 1996; 383: 447-450. (Pubitemid 26330835)
5. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, Barak LS: The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 1999; 96: 3712-3717. (Pubitemid 29168975)
6. Gales C, Rebois RV, Hogue M, Trieu P, Breit A, Hebert TE, Bouvier M: Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods 2005; 2: 177-184. (Pubitemid 41122124)
7. Gales C, Van Durm JJ, Schaak S, Pontier S, Percherancier Y, Audet M, Paris H, Bouvier M: Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 2006; 13: 778-786. (Pubitemid 44338771)
8. Perroy J, Pontier S, Charest PG, Aubry M, Bouvier M: Real-time monitoring of ubiquitination in living cells by BRET. Nat Methods 2004; 1: 203-208.
9. Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, Drucker DJ: International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 2003; 55: 167-194. (Pubitemid 36268402)
10. Holst JJ: The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439. (Pubitemid 350041474)
11. Elling CE, Schwartz TW: Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering. EMBO J 1996; 15: 6213-6219. (Pubitemid 26397894)
12. Jorgensen R, Kubale V, Vrecl M, Schwartz TW, Elling CE: Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s). J Pharmacol Exp Ther 2007; 322: 148-154. (Pubitemid 46956350)
13. Vrecl M, Jorgensen R, Pogacnik A, Heding A: Development of a BRET2 screening assay using beta-arrestin 2 mutants. J Biomol Screen 2004; 9: 322-333.
14. Jorgensen R, Martini L, Schwartz TW, Elling CE: Characterization of glucagon-like peptide-1. receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype. Mol Endocrinol 2005; 19: 812-823. (Pubitemid 40349451)
15. Jorgensen R, Holliday ND, Hansen JL, Vrecl M, Heding A, Schwartz TW, Elling CE: Characterization of g-protein coupled receptor kinase interaction with the neurokinin-1 receptor using bioluminescence resonance energy transfer. Mol Pharmacol 2008; 73: 349-358. (Pubitemid 351159205)
16. Violin JD, Ren XR, Lefkowitz RJ: G-proteincoupled receptor kinase specificity for betaarrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer. J Biol Chem 2006; 281: 20577-20588. (Pubitemid 44065829)
17. Heroux M, Breton B, Hogue M, Bouvier M: Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET. Biochemistry 2007; 46: 7022-7033. (Pubitemid 46906431)
18. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M: Quantitative assessment of beta 1-and beta 2-adrenergic receptor homo-and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 2002; 277: 44925-44931. (Pubitemid 36159089)
19. Krupnick JG, Santini F, Gagnon AW, Keen JH, Benovic JL: Modulation of the arrestinclathrin interaction in cells: characterization of beta-arrestin dominant-negative mutants. J Biol Chem 1997; 272: 32507-32512. (Pubitemid 28011936)
20. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG: Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis * . J Biol Chem 2001; 276: 19452-19460.
21. Widmann C, Dolci W, Thorens B: Internalization and homologous desensitization of the GLP-1 receptor depend on phosphorylation of the receptor carboxyl tail at the same three sites. Mol Endocrinol 1997; 11: 1094-1102. (Pubitemid 27278832)
22. Lohse MJ, Andexinger S, Pitcher J, Trukawinski S, Codina J, Faure JP, Caron MG, Lefkowitz RJ: Receptor-specific desensitization with purified proteins: kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. J Biol Chem 1992; 267: 8558-8564.
23. Sohlemann P, Hekman M, Puzicha M, Buchen C, Lohse MJ: Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein-coupled receptors. Eur J Biochem 1995; 232: 464-472.
24. DeFea KA: Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold? Cell Signal 2011; 23: 621-629.
25. Tesmer VM, Kawano T, Shankaranarayanan A, Kozasa T, Tesmer JJG: Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science 2005; 310: 1686-1690. (Pubitemid 41780792)
26. Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C: Crystal structure of betaarrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Structure 2001; 9: 869-880. (Pubitemid 32913504)
27. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC: High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007; 318: 1258-1265. (Pubitemid 350172884)
28. Ribas C, Penela P, Murga C, Salcedo A, Garcia-Hoz C, Jurado-Pueyo M, Aymerich I, Mayor F Jr: The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 2007; 1768: 913-922. (Pubitemid 46452540)
29. Penela P, Murga C, Ribas C, Lafarga V, Mayor F: The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 2010; 160: 821-832.
30. Nogues L, Salcedo A, Mayor F, Penela P: Multiple scaffolding functions of beta-arrestins in the degradation of G protein-coupled receptor kinase 2. J Biol Chem 2011; 286: 1165-1173.